AIHC Capital Management Ltd — 13F Holdings & Portfolio

CIK 2103725 · latest 13F-HR filed 2026-08-13

AIHC Capital Management Ltd manages $104.2M in 13F-reported U.S. long-equity assets across 4 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (54.46%), ORIC (39.77%), NBP (5.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 1; 2 existing positions rose in reported value and 1 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$104.2M

Long-equity book

Holdings
4

Distinct positions

Period
2026-06-30

Filed 2026-08-13

Q/Q Activity
+0 / −1 / ↑2 / ↓1

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

3 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 100%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 30, 2026.

Address
UNIT 1506, 15/F
NEXXUS BUILDING, 41 CONNAUGHT ROAD CENTRAL
CENTRAL, HONG KONG
Hong Kong
Phone
85237579883
Name Title / Status Ownership Type
AIH CAPITAL GROUP LIMITED ControlSHAREHOLDER
since Jan 2021
75% or moreForeign Entity
Zhang, Wei, NMN ControlDIRECTOR, CHIEF EXECUTIVE OFFICER
since Dec 2018
Less than 5%Individual
Lai, Shuk Ting, NMNCHIEF OPERATING OFFICER
since Sep 2019
Less than 5%Individual
Zhang, Wei, NMN Control
Indirect owner via AIH CAPITAL GROUP LIMITED
SHAREHOLDER
since Jan 2021
75% or moreIndividual
Ownership & leadership changes · 1 filing with changes since Nov 11, 2020

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 24, 2021 filing
  • AddedAIH CAPITAL GROUP LIMITED · SHAREHOLDER · 75% or more · control person
  • AddedZhang, Wei, NMN · SHAREHOLDER · 75% or more · indirect via AIH CAPITAL GROUP LIMITED · control person
  • ChangedZhang, Wei, NMN · title DIRECTOR, SHAREHOLDER, CHIEF EXECUTIVE OFFICER → DIRECTOR, CHIEF EXECUTIVE OFFICER; ownership 75% or more → Less than 5%
Nov 11, 2020 filing (earliest on record)
  • ListedLai, Shuk Ting, NMN · CHIEF OPERATING OFFICER · Less than 5%
  • ListedZhang, Wei, NMN · DIRECTOR, SHAREHOLDER, CHIEF EXECUTIVE OFFICER · 75% or more · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 2 →

Top Trims

Show all 1 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

Show all 1 →

AIHC Capital Management Ltd Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 REVOLUTION MEDICINES INC RVMD 76155X100 $56.8M 54.46% 303,133 SH
2 ORIC PHARMACEUTICALS INC ORIC 68622P109 $41.5M 39.77% 3,828,460 SH
3 NOVABRIDGE BIOSCIENCES NBP 44975P103 $5.6M 5.38% 2,878,033 SH
4 KORRO BIO INC KRRO 500946108 $398.9K 0.38% 30,265 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $104.2M 4 0001172661-26-003381
2026-03-31 2026-05-08 $119.7M 5 0001172661-26-001629
2025-12-31 2026-02-05 $106.7M 6 0001172661-26-000478
Filer Information
Address
UNIT 1506, 15/F, NEXXUS BUILDING
41 CONNAUGHT ROAD CENTRAL
CENTRAL 00000
Phone
85237579883
Filing Manager
AIHC Capital Management Ltd
CENTRAL, K3
Signatory
Teresa Lai
Chief Operating Officer